Ligita Jančorienė

Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Alison D. Marshall, Evan B. Cunningham, Stine Nielsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 150 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutical Policy +13

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial

Jan Šperl, Gábor Horváth, Waldemar Halota et al. · Journal of Hepatology · 2016 · 54 citations

Pharmacy, Internal Medicine, Pharmacotherapy +10

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

Marine Maurel, Jennifer Howard, Esther Kissling et al. · Eurosurveillance · 2024 · 50 citations · Full text

Veterinary Medicine, Infectious Diseases, Immunization +14

Epidemiological patterns of tick‐borne encephalitis in Lithuania and clinical features in adults in the light of the high incidence in recent years: a retrospective study

Daiva Radzišauskienė, Kęstutis Žagminas, Loreta Ašoklienė et al. · European Journal of Neurology · 2017 · 47 citations · Full text

Veterinary Medicine, Infectious Diseases, Neurology +12

Comparison of mortality risk evaluation tools efficacy in critically ill COVID-19 patients

Vaidas Vicka, Elija Januškevičiūtė, Sigutė Miškinytė et al. · BMC Infectious Diseases · 2021 · 38 citations · Full text

Medicine, Internal Medicine, Critical Care Medicine +12